Thank you for sharing!

Your article was successfully shared with the contacts you provided.
How Ambien maker Sanofi responded on Twitter to Roseanne Barr, who name-dropped the drug in responding to criticism about an offensive tweet.

On Tuesday, as the actor Roseanne Barr grappled with the public outcry over an offensive tweet that drove ABC to cancel her eponymously named show, she returned to Twitter to apologize and offer excuses. It was Memorial Day, she said. It was early in the morning. “I was ambien tweeting,” Barr told her followers.

C. Ryan Barber

C. Ryan Barber, based in Washington, covers government affairs and regulatory compliance. Contact him at cbarber@alm.com. On Twitter: @cryanbarber

More from this author

Lean Adviser Legal

Think Lean Daily Message

"Facts are what they are. You can t make them, manage them or control them. But what we can do is try to find them and figure out how to live with them. But future events are essentially fickle. The requirement is not investigation, it is risk assessment, and the techniques are quite different. And opinions are unlike either of the above. They are the view from inside someone s head, someone who matters. And sometimes you can change them."

Learn More


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.